Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Apply
Saroglitazar Magnesium
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step